OCA at 08:53, 21 February 2024

2024-02-21T08:53:45Z

←Older revision		Revision as of 08:53, 21 February 2024
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 8chf is ~~ON HOLD~~	+	==cryo-EM Structure of Craf:14-3-3:Mek1==
-		+	<StructureSection load='8chf' size='340' side='right'caption='[[8chf]], [[Resolution\|resolution]] 4.25Å' scene=''>
-	~~Authors~~:	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[8chf]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Spodoptera_frugiperda Spodoptera frugiperda]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8CHF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8CHF FirstGlance]. <br>
-	~~Description~~:	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution\|Resolution]] 4.25Å</td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=29L:2-{4-[(1E)-1-(HYDROXYIMINO)-2,3-DIHYDRO-1H-INDEN-5-YL]-3-(PYRIDIN-4-YL)-1H-PYRAZOL-1-YL}ETHANOL'>29L</scene>, <scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8chf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8chf OCA], [https://pdbe.org/8chf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8chf RCSB], [https://www.ebi.ac.uk/pdbsum/8chf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8chf ProSAT]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[https://www.uniprot.org/uniprot/RAF1_HUMAN RAF1_HUMAN] Defects in RAF1 are the cause of Noonan syndrome type 5 (NS5) [MIM:[https://omim.org/entry/611553 611553]. Noonan syndrome (NS) is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. It is a genetically heterogeneous and relatively common syndrome, with an estimated incidence of 1 in 1000-2500 live births.<ref>PMID:17603483</ref> <ref>PMID:17603482</ref> <ref>PMID:20683980</ref> Defects in RAF1 are the cause of LEOPARD syndrome type 2 (LEOPARD2) [MIM:[https://omim.org/entry/611554 611554]. LEOPARD syndrome is an autosomal dominant disorder allelic with Noonan syndrome. The acronym LEOPARD stands for lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and deafness.<ref>PMID:17603483</ref>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/RAF1_HUMAN RAF1_HUMAN] Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation.<ref>PMID:9360956</ref> <ref>PMID:11427728</ref> <ref>PMID:11719507</ref> <ref>PMID:15385642</ref> <ref>PMID:15618521</ref> <ref>PMID:15849194</ref> <ref>PMID:16924233</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Homo sapiens]]
		+	[[Category: Large Structures]]
		+	[[Category: Spodoptera frugiperda]]
		+	[[Category: Dedden D]]
		+	[[Category: Ulrich G]]

OCA at 08:45, 17 January 2024

2024-01-17T08:45:52Z

←Older revision		Revision as of 08:45, 17 January 2024
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 8chf is ON HOLD ~~until Paper Publication~~	+	The entry 8chf is ON HOLD

	Authors:		Authors:

OCA at 05:32, 8 March 2023

2023-03-08T05:32:27Z

←Older revision		Revision as of 05:32, 8 March 2023
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 8chf is ON HOLD	+	The entry 8chf is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "8chf" [edit=sysop:move=sysop]

2023-02-15T08:37:22Z

Protected "8chf" [edit=sysop:move=sysop]

←Older revision

Revision as of 08:37, 15 February 2023

OCA: New page: '''Unreleased structure''' The entry 8chf is ON HOLD Authors: Description: Category: Unreleased Structures

2023-02-15T08:37:20Z

New page: '''Unreleased structure''' The entry 8chf is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 8chf is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]

8chf - Revision history

OCA at 08:53, 21 February 2024

OCA at 08:45, 17 January 2024

OCA at 05:32, 8 March 2023

OCA: Protected "8chf" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 8chf is ON HOLD Authors: Description: Category: Unreleased Structures